The Medicines and Healthcare products Regulatory Agency (MHRA) offers a 150-day assessment timeline for all high-quality marketing authorisation applications. A total of 1,016 medicinal products have been waiting for MHRA marketing authorisation approval for more than 150 days. Of these, 36 are for women’s health.